American Hospital Formulary Service, American Society of Hospital Pharmacists, Washington, D. C. (R)
2.
Anon.: Drug Interactions That Can Affect Your Patient, Patient Care1: 32 (Nov.) 1967. (R)
3.
Anon.: Anticoagulants: Drug Interactions, Clin-Alert No. 103, May 8, 1968. (R)
4.
Anon.: Effect of pH of the Urine on Antimicrobial Therapy of Urinary Tract Infections, Med. Letter9: 47 (June 16) 1967. (R)
5.
AntonA. H.: A Drug-Induced Change in the Distribution and Renal Excretion of Sulfonamides, J. Pharmacol. Exptl. Therap.129: 282, 1960. (OA)
6.
BleifeldW., and GehrmannG.: Disturbance of Vitamin B12 Absorption by PAS Therapy, Deut. Med. Wochschr.90: 1765 (Oct. 1) 1965. (OH)
7.
BrodieB. B.: Displacement of One Drug by Another From Carrier or Receptor Sites, Proc. Roy. Soc. Med.58: 946 (Nov.) 1965. (R)
8.
BurnsJ. J., and ConneyA. H.: Enzyme Stimulation and Inhibition in the Metabolism of Drugs, Proc. Roy. Soc. Med.58: 955 (Nov.) 1965. (R)
9.
ChristensenL. K., HansenJ. M., and KristensenM.: Sulphaphenazole-Induced Hypoglycaemic Attacks in Tolbutamide-Treated Diabetics, Lancet2: 1298 (Dec. 21) 1963. (OH)
10.
CucinellS. A.: Drug Interactions in Man: I. Lowering Effect of Phenobarbital on Plasma Levels of Bishydroxycoumarin (Dicumarol) and Diphenylhydantoin (Di-lantin), Clin. Pharmacol. Therap.6: 420 (July–Aug.) 1965. (OH)
11.
DixonR. L., HendersonE. S., and RallD. P.: Plasma Protein Binding of Methotrexate and Its Displacement by Various Drugs, Fed. Proc.24: 454, 1965. (O) (Abstract from paper at 49th Annual Meeting, 1965)
DubachU. C., BuckertA., and RaaflaubJ.: Einfluss von Sulfonamiden auf du Blutzuckersenkende Wirkung Oraler Antidiabetica, Schweiz Med. Wschr.96: 1483, 1966:
14.
ElkingM. P.Sr., and KabatH. F.: Drug Induced Modifications of Laboratory Test Values, Am. J. Hosp. Pharm.25: 485 (Sept.) 1968. (R)
15.
GaleG. R., and OdellC. A.: Antagonism of Colistin-Sulphonamide Synergism by Para-Aminobenzoic Acid, Nature (London)209: 1357 (Mar. 26) 1966. (OT)
KlotzM., RichterH., and MeuffelsM.: Interference by Formaldehyde-Forming Drugs in the Determinations of Urinary Catecholamines, Clin. Chem.19: 372, 1964.
18.
KuninC. M.: Enhancement of Antimicrobial Activity of Penicillins and Other Antibiotics in Human Serum by Competitive Serum Binding Inhibitors, Proc. Soc. Exptl. Biol. Med.117: 69 (Oct.) 1964. (OT)
19.
KuttH., WintersW., and McDowellF. H.: Depression of Prohydroxylation of Diphenylhydantoin by Antituberculosis Chemotherapy, Neurology16: 594 (June) 1966. (OH)
20.
KuttH., VerebelyK., and McDowellF.: Inhibition of Diphenylhydantoin Metabolism in Rats and in Rat Liver Microsomes by Antitubercular Drugs, Neurology18: 706 (July) 1968. (OA)
21.
LansdownF. S., BeranM., and LitwakT.: Psychotoxic Reaction During Ethionamide Therapy, Am. Rev. Resp. Diseases95: 1053 (June) 1967. (C)
22.
MacDonaldH., PlaceV. A., FalkH., and DarkenM. A.: Effect of Food on Absorption of Sulfonamides in Man, Chemotherapia12: 282, 1967. (OH)
23.
MilneM. D.: Influence of Acid-Base Balance on Efficacy and Toxicity of Drugs, Proc. Roy. Soc. Med.58: 961 (Nov.) 1965. (R)
24.
ModellW.: Drugs of Choice 1966–1967, C. V. Mosby Co., St. Louis. (R)
25.
OdellG. B.: The Dissociation of Bilirubin from Albumin and Its Clinical Implications, J. Pediat.55: 268 (Sept.) 1959. (R)
26.
PalmD.: Hemmung der Monoaminoxydase Durch Bakteriostatisch Wirksame Nitrofuran-Derivat, Naunyn Schmiedeberg Arch. Exp. Path.256/2: 281 (Jan. 17) 1967. (OA)
27.
PermanE. S.: Intolerance to Alcohol (Letters), New Engl. J. Med.273: 114 (July 8) 1965. (C)
28.
PettingerW. A., SoyangcoF. G., and OatesJ. A.: Monoamine-oxidase Inhibition by Furazolidone in Man, Clin. Res.14: 258 (Apr.) 1966 (abstract). (OHA)
29.
RonaldA. R., TurckM., and PetersdorfR. G.: A Critical Evaluation of Nalidixic Acid in Urinary-Tract Infections, New Engl. J. Med.275: 1081 (Nov. 17) 1966. (R)
30.
ShepherdM.: Clinically Important Examples of Drug Interaction. Psychotropic Drugs (I). Interaction Between Centrally Acting Drugs in Man: Some General Considerations, Proc. Roy. Soc. Med.58: 964 (Nov.) 1965. (R)
31.
SilvermanW. A.: A Difference in Mortality Rate and Incidence of Kernicterus Among Premature Infants Allotted to Two Prophylactic Antibacterial Regimens, Pediatrics18: 614 (Oct.) 1956. (OH)